Key points are not available for this paper at this time.
Background Numerous clinical trials have supported psychedelic-assisted therapy (PAT) as a treatment for psychiatric disorders such as depression, anxiety, post-traumatic stress, and substance use. While empirical evidence indicates PAT's benefits, the perspectives of mental health practitioners on this topic remain unclear.
Kraiem et al. (Tue,) studied this question.